Sommadossi Jean-Pierre
Insider CIK 1296995 · AVIR President, CEO, and Chairman, Director · KZR Director · ABGI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2026-02-03 | 2026-02-03 | 300,000 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2026-02-03 | 2026-02-03 | 300,000 | $1.24 | $372.0K | 767,830 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2026-01-31 | 2026-02-03 | 99,517 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2026-01-31 | 2026-02-03 | 173,466 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2026-01-31 | 2026-02-03 | 272,983 | — | $0 | 573,923 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | F Tax w/h | 2026-01-31 | 2026-02-03 | 106,093 | $4.24 | $449.8K | 467,830 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2025-01-31 | 2025-02-04 | 173,467 | — | $0 | 173,466 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 99,518 | — | $0 | 99,518 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 440,000 | — | $0 | 440,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | F Tax w/h | 2025-01-31 | 2025-02-04 | 88,601 | $3.06 | $271.1K | 300,940 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2025-01-31 | 2025-02-04 | 173,467 | — | $0 | 290,024 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award | 2025-01-31 | 2025-02-04 | 99,517 | — | $0 | 389,541 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | S Sale | 2024-09-19 | 2024-09-19 | 1,841 | $4.00 | $7.4K | 5,866,025 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | S Sale | 2024-09-18 | 2024-09-19 | 22,187 | $4.03 | $89.4K | 5,867,866 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | S Sale | 2024-09-17 | 2024-09-19 | 33,941 | $4.05 | $137.5K | 5,890,053 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | S Sale | 2024-06-05 | 2024-06-07 | 1,006 | $4.00 | $4.0K | 5,923,994 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 56,910 | $3.85 | $219.1K | 116,557 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2024-01-31 | 2024-02-02 | 173,467 | — | $0 | 346,933 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 448,000 | — | $0 | 448,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2024-01-31 | 2024-02-02 | 173,467 | — | $0 | 173,467 | SEC↗ |
| ABGI ABG Acquisition Corp. I | D To issuer deriv | 2023-03-01 | 2023-03-03 | 32,500 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 520,400 | — | $0 | 520,400 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 728,600 | — | $0 | 728,600 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 378,033 | — | $0 | 378,033 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2021-06-28 | 2021-06-30 | 26,000 | — | $0 | 26,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2021-01-29 | 2021-02-01 | 640,000 | — | $0 | 640,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-03 | 750,000 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion | 2020-11-03 | 2020-11-03 | 750,000 | — | $0 | 5,925,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2020-06-24 | 2020-06-26 | 8,896 | — | $0 | 8,896 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 8,896 | — | $0 | 8,896 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 52,581 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 35,258 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion | 2018-06-25 | 2018-06-27 | 52,581 | — | $0 | 143,182 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion | 2018-06-25 | 2018-06-27 | 35,258 | — | $0 | 178,440 | SEC↗ |